Evidence map›Paper›PMID 27437069›Full record

ArticleOxidative medicine and cellular longevity2016

Identification of Redox and Glucose-Dependent Txnip Protein Interactions.

Benjamin J Forred, Skyla Neuharth, Dae In Kim, Michael W Amolins, Khatereh Motamedchaboki, Kyle J Roux, Peter F Vitiello

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Gene Therapies for Retinitis Pigmentosa that Target Glucose Metabolism.Cold Spring Harbor perspectives in medicine · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Benjamin J ForredChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA.ORCID 0000-0002-5340-6886
Skyla NeuharthChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA.
Dae In KimChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA.
Michael W AmolinsChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA.ORCID 0000-0002-4133-7510
Khatereh MotamedchabokiProteomics Facility, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Kyle J RouxChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA; Department of Pediatrics, Sanford School of Medicine, The University of South Dakota, Sioux Falls, SD 57105, USA.
Peter F VitielloChildren's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA; Department of Pediatrics, Sanford School of Medicine, The University of South Dakota, Sioux Falls, SD 57105, USA.ORCID 0000-0001-5344-9192

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Maximiliano A DAngelo · 1985 to 2026
$107.2M
Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Developing methods for proximity-dependent protein labelingR01GM102203 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2017
$1.5M
Sanford Research/USD Science Educator Pediatric Health and Research FellowshipR25HD072596 · NICHD · SANFORD RESEARCH/USD · PI ELLIOTT, AMY J, PEARCE, DAVID A. · 2012 to 2016
$474k
NCI NIH HHS P30 CA030199NICHD NIH HHS R25 HD072596NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620NIGMS NIH HHS R01 GM102203
6 · The paper itself

Abstract

Thioredoxin-interacting protein (Txnip) acts as a negative regulator of thioredoxin function and is a critical modulator of several diseases including, but not limited to, diabetes, ischemia-reperfusion cardiac injury, and carcinogenesis. Therefore, Txnip has become an attractive therapeutic target to alleviate disease pathologies. Although Txnip has been implicated with numerous cellular processes such as proliferation, fatty acid and glucose metabolism, inflammation, and apoptosis, the molecular mechanisms underlying these processes are largely unknown. The objective of these studies was to identify Txnip interacting proteins using the proximity-based labeling method, BioID, to understand differential regulation of pleiotropic Txnip cellular functions. The BioID transgene fused to Txnip expressed in HEK293 identified 31 interacting proteins. Many protein interactions were redox-dependent and were disrupted through mutation of a previously described reactive cysteine (C247S). Furthermore, we demonstrate that this model can be used to identify dynamic Txnip interactions due to known physiological regulators such as hyperglycemia. These data identify novel Txnip protein interactions and demonstrate dynamic interactions dependent on redox and glucose perturbations, providing clarification to the pleiotropic cellular functions of Txnip.

Indexed as

Protein Interaction MappingCarrier ProteinsGlucoseHEK293 CellsHumansOxidation-ReductionProtein BindingCarrier ProteinsGlucoseTXNIP protein, human

Identifiers

PMID27437069
PMCPMC4942636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.